Report Detail
Global Coronary Heart Disease Occluder Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4697387 |
- 21 May, 2026 |
- Global |
- 102 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Coronary Heart Disease Occluder market size was valued at US$ 299 million in 2025 and is forecast to a readjusted size of US$ 450 million by 2032 with a CAGR of 6.1% during review period.
CHD occluders are medical devices intended for the closure of the remnant opening, or a defect, in the heart resulting from congenital abnormal development.
The coronary heart disease occluder market is driven by the increasing prevalence of coronary heart disease (CHD) and the demand for minimally invasive treatment options. CHD is a leading cause of morbidity and mortality worldwide, leading to the need for effective and safe treatment devices. Coronary heart disease occluders are specialized devices used in percutaneous procedures to close or occlude abnormal openings in the heart, such as septal defects or patent foramen ovale. These occluders offer advantages over traditional surgical methods, such as reduced procedural risks, shorter hospital stays, and quicker recovery times. Moreover, advancements in medical technology and imaging techniques have improved the accuracy and success rates of these procedures, contributing to market growth. However, the market also faces challenges, including the high cost of occluder devices and the need for specialized training for healthcare professionals performing these procedures. Additionally, the stringent regulatory approval process for medical devices poses obstacles to new market entrants. To succeed, manufacturers need to focus on cost-effectiveness, continuous innovation, and collaboration with healthcare providers to improve patient outcomes and expand their presence in the coronary heart disease occluder market.
This report is a detailed and comprehensive analysis for global Coronary Heart Disease Occluder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Coronary Heart Disease Occluder market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Coronary Heart Disease Occluder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Coronary Heart Disease Occluder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Coronary Heart Disease Occluder market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Coronary Heart Disease Occluder
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Coronary Heart Disease Occluder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Coronary Heart Disease Occluder market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ASD Occluder
VSD Occluder
PDA Occluder
Market segment by Application
Hospitals
Clinics
Major players covered
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Coronary Heart Disease Occluder product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Coronary Heart Disease Occluder, with price, sales quantity, revenue, and global market share of Coronary Heart Disease Occluder from 2021 to 2026.
Chapter 3, the Coronary Heart Disease Occluder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Coronary Heart Disease Occluder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Coronary Heart Disease Occluder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Coronary Heart Disease Occluder.
Chapter 14 and 15, to describe Coronary Heart Disease Occluder sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Coronary Heart Disease Occluder Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 ASD Occluder
- 1.3.3 VSD Occluder
- 1.3.4 PDA Occluder
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Coronary Heart Disease Occluder Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.5 Global Coronary Heart Disease Occluder Market Size & Forecast
- 1.5.1 Global Coronary Heart Disease Occluder Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Coronary Heart Disease Occluder Sales Quantity (2021-2032)
- 1.5.3 Global Coronary Heart Disease Occluder Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Abbott
- 2.1.1 Abbott Details
- 2.1.2 Abbott Major Business
- 2.1.3 Abbott Coronary Heart Disease Occluder Product and Services
- 2.1.4 Abbott Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Abbott Recent Developments/Updates
- 2.2 Boston Scientific
- 2.2.1 Boston Scientific Details
- 2.2.2 Boston Scientific Major Business
- 2.2.3 Boston Scientific Coronary Heart Disease Occluder Product and Services
- 2.2.4 Boston Scientific Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Boston Scientific Recent Developments/Updates
- 2.3 LifeTech
- 2.3.1 LifeTech Details
- 2.3.2 LifeTech Major Business
- 2.3.3 LifeTech Coronary Heart Disease Occluder Product and Services
- 2.3.4 LifeTech Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 LifeTech Recent Developments/Updates
- 2.4 Lepu Medical
- 2.4.1 Lepu Medical Details
- 2.4.2 Lepu Medical Major Business
- 2.4.3 Lepu Medical Coronary Heart Disease Occluder Product and Services
- 2.4.4 Lepu Medical Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Lepu Medical Recent Developments/Updates
- 2.5 Occlutech
- 2.5.1 Occlutech Details
- 2.5.2 Occlutech Major Business
- 2.5.3 Occlutech Coronary Heart Disease Occluder Product and Services
- 2.5.4 Occlutech Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Occlutech Recent Developments/Updates
- 2.6 W. L. Gore & Associates
- 2.6.1 W. L. Gore & Associates Details
- 2.6.2 W. L. Gore & Associates Major Business
- 2.6.3 W. L. Gore & Associates Coronary Heart Disease Occluder Product and Services
- 2.6.4 W. L. Gore & Associates Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 W. L. Gore & Associates Recent Developments/Updates
- 2.7 Starway
- 2.7.1 Starway Details
- 2.7.2 Starway Major Business
- 2.7.3 Starway Coronary Heart Disease Occluder Product and Services
- 2.7.4 Starway Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Starway Recent Developments/Updates
- 2.8 Coherex Medical
- 2.8.1 Coherex Medical Details
- 2.8.2 Coherex Medical Major Business
- 2.8.3 Coherex Medical Coronary Heart Disease Occluder Product and Services
- 2.8.4 Coherex Medical Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Coherex Medical Recent Developments/Updates
- 2.9 Cardia
- 2.9.1 Cardia Details
- 2.9.2 Cardia Major Business
- 2.9.3 Cardia Coronary Heart Disease Occluder Product and Services
- 2.9.4 Cardia Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Cardia Recent Developments/Updates
- 2.10 MicroPort
- 2.10.1 MicroPort Details
- 2.10.2 MicroPort Major Business
- 2.10.3 MicroPort Coronary Heart Disease Occluder Product and Services
- 2.10.4 MicroPort Coronary Heart Disease Occluder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 MicroPort Recent Developments/Updates
3 Competitive Environment: Coronary Heart Disease Occluder by Manufacturer
- 3.1 Global Coronary Heart Disease Occluder Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Coronary Heart Disease Occluder Revenue by Manufacturer (2021-2026)
- 3.3 Global Coronary Heart Disease Occluder Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Coronary Heart Disease Occluder by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Coronary Heart Disease Occluder Manufacturer Market Share in 2025
- 3.4.3 Top 6 Coronary Heart Disease Occluder Manufacturer Market Share in 2025
- 3.5 Coronary Heart Disease Occluder Market: Overall Company Footprint Analysis
- 3.5.1 Coronary Heart Disease Occluder Market: Region Footprint
- 3.5.2 Coronary Heart Disease Occluder Market: Company Product Type Footprint
- 3.5.3 Coronary Heart Disease Occluder Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Coronary Heart Disease Occluder Market Size by Region
- 4.1.1 Global Coronary Heart Disease Occluder Sales Quantity by Region (2021-2032)
- 4.1.2 Global Coronary Heart Disease Occluder Consumption Value by Region (2021-2032)
- 4.1.3 Global Coronary Heart Disease Occluder Average Price by Region (2021-2032)
- 4.2 North America Coronary Heart Disease Occluder Consumption Value (2021-2032)
- 4.3 Europe Coronary Heart Disease Occluder Consumption Value (2021-2032)
- 4.4 Asia-Pacific Coronary Heart Disease Occluder Consumption Value (2021-2032)
- 4.5 South America Coronary Heart Disease Occluder Consumption Value (2021-2032)
- 4.6 Middle East & Africa Coronary Heart Disease Occluder Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Coronary Heart Disease Occluder Sales Quantity by Type (2021-2032)
- 5.2 Global Coronary Heart Disease Occluder Consumption Value by Type (2021-2032)
- 5.3 Global Coronary Heart Disease Occluder Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Coronary Heart Disease Occluder Sales Quantity by Application (2021-2032)
- 6.2 Global Coronary Heart Disease Occluder Consumption Value by Application (2021-2032)
- 6.3 Global Coronary Heart Disease Occluder Average Price by Application (2021-2032)
7 North America
- 7.1 North America Coronary Heart Disease Occluder Sales Quantity by Type (2021-2032)
- 7.2 North America Coronary Heart Disease Occluder Sales Quantity by Application (2021-2032)
- 7.3 North America Coronary Heart Disease Occluder Market Size by Country
- 7.3.1 North America Coronary Heart Disease Occluder Sales Quantity by Country (2021-2032)
- 7.3.2 North America Coronary Heart Disease Occluder Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Coronary Heart Disease Occluder Sales Quantity by Type (2021-2032)
- 8.2 Europe Coronary Heart Disease Occluder Sales Quantity by Application (2021-2032)
- 8.3 Europe Coronary Heart Disease Occluder Market Size by Country
- 8.3.1 Europe Coronary Heart Disease Occluder Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Coronary Heart Disease Occluder Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Coronary Heart Disease Occluder Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Coronary Heart Disease Occluder Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Coronary Heart Disease Occluder Market Size by Region
- 9.3.1 Asia-Pacific Coronary Heart Disease Occluder Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Coronary Heart Disease Occluder Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Coronary Heart Disease Occluder Sales Quantity by Type (2021-2032)
- 10.2 South America Coronary Heart Disease Occluder Sales Quantity by Application (2021-2032)
- 10.3 South America Coronary Heart Disease Occluder Market Size by Country
- 10.3.1 South America Coronary Heart Disease Occluder Sales Quantity by Country (2021-2032)
- 10.3.2 South America Coronary Heart Disease Occluder Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Coronary Heart Disease Occluder Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Coronary Heart Disease Occluder Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Coronary Heart Disease Occluder Market Size by Country
- 11.3.1 Middle East & Africa Coronary Heart Disease Occluder Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Coronary Heart Disease Occluder Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Coronary Heart Disease Occluder Market Drivers
- 12.2 Coronary Heart Disease Occluder Market Restraints
- 12.3 Coronary Heart Disease Occluder Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Coronary Heart Disease Occluder and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Coronary Heart Disease Occluder
- 13.3 Coronary Heart Disease Occluder Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Coronary Heart Disease Occluder Typical Distributors
- 14.3 Coronary Heart Disease Occluder Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Coronary Heart Disease Occluder. Industry analysis & Market Report on Coronary Heart Disease Occluder is a syndicated market report, published as Global Coronary Heart Disease Occluder Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Coronary Heart Disease Occluder market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
